+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fusion Biopsy Market by Route Type, Product, Application, End User, and Region - Global Forecast to 2029

  • PDF Icon

    Report

  • 197 Pages
  • December 2024
  • Region: Global
  • Markets and Markets
  • ID: 6036241
Description Jump to:
The global fusion biopsy market is valued at an estimated USD 0.65 billion in 2024 and is projected to reach USD 0.91 billion by 2029, at a CAGR of 7.1% during the forecast period. The old population is causing a rise in age-related health conditions, such as prostate cancer, which predominantly affects older men. As these elderly individuals grows globally, the incidence of prostate cancer is also expected to increase leading to increased demand for advanced diagnostic technologies such as fusion biopsy. The increase in demand is especially seen in areas with older populations, like Europe and North America. These regions have healthcare systems that are better able to use advanced technologies like fusion biopsy.

The equipment segment is projected to witness the highest growth rate in the fusion biopsy market, by product, during the forecast period.

Based on product, the fusion biopsy market is segmented into equipment and consumables. The growth of equipment segment is owing to their ability to combine high-resolution imaging with real-time ultrasound for precise targeting of suspicious lesions. The demand for these equipment is fueled by the increasing prevalence of prostate cancer, the adoption of minimally invasive procedures, and ongoing technological advancements, such as AI integration for better lesion detection, further accelerates the growth of this segment.

In 2023, the prostate cancer segment accounted for the largest share of the fusion biopsy market, by application.

Prostate cancer and other applications make up the application-based segments of the fusion biopsy market. Market share for fusion biopsy was highest in the prostate cancer in 2023. The high incidence of prostate cancer worldwide and the efficiency of fusion biopsy in identifying these clinically relevant malignancies are the primary causes of this high percentage. Improvements in imaging technology and growing awareness of early detection further support this the lead, guaranteeing its sustained market leadership in fusion biopsy.

The Asia Pacific region is projected to witness highest growth rate in the fusion biopsy market during the forecast period

The global fusion biopsy market is segmented into six regions - North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the fusion biopsy market is expected to grow at the fastest rate in the Asia Pacific region. The rising healthcare investments, a growing prevalence of cancers like prostate cancer, and a large aging population vulnerable to cancer contribute to the significant market growth in the Aisa Pacific region during the projected period.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 35%, Europe - 31%, Asia Pacific - 22%, Latin America - 9%, Middle East & Africa - 2%, and the GCC Countries - 1%

Lists of Companies Profiled in the Report:

Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), KOELIS (France), FUJIFILM Holdings Corporation (Japan), Eigen Health (US), Focal Healthcare (Canada), Esaote SPA (Italy), MTT GmbH (Germany), MedCom (Germany), UC-CARE Medical Systems (US), Biobot Surgical (Singapore), Canon Inc. (Japan), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)

Research Coverage:

In this report, the fusion biopsy market has been categorized based on product (equipment and consumables), end user (hospitals and other end users), route type (transsrectal, transperineal, and other route types), application (prostate cancer and other applications), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).

Comprehensive information regarding the main drivers, barriers, opportunities, and challenges influencing the fusion biopsy market's expansion is included in detail in this study. An exhaustive study of the key players in the fusion biopsy market has been done to provide insights into their business profile, products offered, noteworthy strategies, collaborations, and other recent activities pertaining to the market.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall fusion biopsy market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, challenges, opportunities, and restaints.

The report provides insights on the following pointers:

  • Analysis of key drivers: (Increasing prevalence of prostate cancer and growing gearitric population, availability of reimbursements and investments by public and private sector, and rising prevalence of minimally invasive surgery), restraints (High cost of fusio biopsy system and alternative methods for fusion biopsy), opportunities (Rise in prevalence of prostate cancer in emerging economies and technological advancements in fusion biopsy devices), and challenges (Paucity of skilled professionals and limited reimbursement in few countries) influencing the growth of the in fusion biopsy market.
  • Product Development/ Innovation: Detailed insights on upcoming technologies, research development activities, and new product launches in the fusion biopsy market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the fusion biopsy market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the fusion biopsy market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), and KOELIS (France) are among others, in the fusion biopsy market strategies.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered & Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Data from Primary Sources
2.1.2.3 Key Industry Insights
2.1.2.4 Breakdown of Primary Interviews
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.1.1 Approach 1: Company Revenue Estimation Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Analysis
2.5 Study Assumptions
2.6 Growth Rate Assumptions
2.7 Research Limitations
2.7.1 Methodology-Related Limitations
2.7.2 Scope-Related Limitations
2.8 Risk Assessment
3 Executive Summary
4 Premium Insights
4.1 Fusion Biopsy Market Overview
4.2 North America: Fusion Biopsy Market, by Application and Country (2023)
4.3 Fusion Biopsy Market: Geographic Growth Opportunities
4.4 Fusion Biopsy Market: Regional Mix (2024-2029)
4.5 Fusion Biopsy Market: Developed vs. Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Prostate Cancer and Growing Geriatric Population
5.2.1.2 Availability of Reimbursements and Investments by Public and Private Sectors
5.2.1.3 Rising Prevalence of Minimally Invasive Surgery
5.2.2 Restraints
5.2.2.1 High Costs of Fusion Biopsy Systems
5.2.2.2 Alternative Methods for Fusion Biopsy
5.2.3 Opportunities
5.2.3.1 Rise in Prevalence of Prostate Cancer in Emerging Economies
5.2.3.2 Technological Advancements in Fusion Biopsy Devices
5.2.4 Challenges
5.2.4.1 Paucity of Skilled Professionals
5.2.4.2 Limited Reimbursement in Few Countries
5.3 Pricing Analysis
5.3.1 Pricing Analysis, by Region
5.3.2 Pricing Analysis, by Product
5.4 Value Chain Analysis
5.5 Supply Chain Analysis
5.6 Ecosystem Analysis
5.6.1 Fusion Biopsy Market: Role of Companies in Ecosystem
5.7 Porter's Five Forces Analysis
5.7.1 Threat of New Entrants
5.7.2 Threat of Substitutes
5.7.3 Bargaining Power of Buyers
5.7.4 Bargaining Power of Suppliers
5.7.5 Intensity of Competitive Rivalry
5.8 Key Stakeholders and Buying Criteria
5.8.1 Key Stakeholders in Buying Process
5.8.2 Buying Criteria
5.9 Regulatory Landscape
5.9.1 North America
5.9.1.1 US
5.9.1.2 Canada
5.9.2 Europe
5.9.3 Asia-Pacific
5.9.3.1 Japan
5.9.3.2 China
5.9.3.3 India
5.9.4 Latin America
5.9.4.1 Brazil
5.9.4.2 Mexico
5.9.5 Middle East
5.9.6 Africa
5.9.7 List of Regulatory Bodies, Government Agencies, and Other Organizations
5.10 Trade Analysis
5.10.1 Trade Analysis for Fusion Biopsy Market
5.11 Patent Analysis
5.12 Key Conferences and Events in 2024-2026
5.13 Trends/Disruptions Impacting Customer Business
5.14 Technology Analysis
5.14.1 Key Technologies
5.14.1.1 MRI-Ultrasound Fusion Imaging
5.14.2 Complementary Technologies
5.14.2.1 Liquid Biopsy
5.14.2.1.1 Digital Droplet Pcr
5.14.2.1.2 Tagged-Amplicon Deep Sequencing
5.15 Investment & Funding Scenario
5.16 Impact of Generative Artificial Intelligence on Fusion Biopsy Market
6 Fusion Biopsy Market, by Route Type
6.1 Introduction
6.2 Transrectal
6.2.1 Heightened Potential for Serious Infections to Hinder Market Growth
6.3 Transperineal
6.3.1 Improved Cancer Detection Through Combination of MRI and Ultrasound to Fuel Market Growth
6.4 Other Route Types
7 Fusion Biopsy Market, by Application
7.1 Introduction
7.2 Prostate Cancer
7.2.1 Precise and Reliable Results of Prostate Fusion Biopsy to Accelerate Market Growth
7.3 Other Applications
8 Fusion Biopsy Market, by Product
8.1 Introduction
8.2 Equipment
8.2.1 Substantial Initial Investments to Ensure Market Growth
8.3 Consumables
8.3.1 Increasing Application of Innovative Technologies and Methodologies to Propel Market Growth
9 Fusion Biopsy Market, by End-user
9.1 Introduction
9.2 Hospitals
9.2.1 Rising Demand for Quick and Accurate Diagnosis to Promote Market Growth
9.3 Other End-users
10 Fusion Biopsy Market, by Region
10.1 Introduction
10.2 North America
10.2.1 Macroeconomic Outlook for North America
10.2.2 US
10.2.2.1 Funding for Cancer Research and Availability of Technologically Advanced Products to Propel Market Growth
10.2.3 Canada
10.2.3.1 Surging Need for Advanced Diagnostic Solutions to Drive Market
10.3 Europe
10.3.1 Macroeconomic Outlook for Europe
10.3.2 Germany
10.3.2.1 Rising Healthcare Expenditure and Increasing Incidence of Cancer to Bolster Market Growth
10.3.3 UK
10.3.3.1 Enhanced Clinical Infrastructure to Accelerate Fusion Biopsy Adoption
10.3.4 France
10.3.4.1 Effective Reimbursement Policies and Government Support for Surgical Product Manufacturers to Augment Market
10.3.5 Italy
10.3.5.1 Rising Healthcare Demands of Geriatric Population to Support Market Growth
10.3.6 Spain
10.3.6.1 Improved Healthcare Infrastructure and Rising Geriatric Demographics to Boost Market
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Macroeconomic Outlook for Asia-Pacific
10.4.2 China
10.4.2.1 Increasing Disposable Income of Middle-Class Population and Rising Diagnostic Procedures to Boost Market
10.4.3 Japan
10.4.3.1 Robust Healthcare System and Surging Need for Precise Early Cancer Detection to Support Market Growth
10.4.4 India
10.4.4.1 Large Patient Population and Increasing Healthcare Investments to Drive Market
10.4.5 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Low Focus on Infrastructural Improvement and Poor Distribution of Resources Likely to Hinder Market Growth
10.5.2 Macroeconomic Outlook for Latin America & Caribbean
10.6 Middle East & Africa
10.6.1 Expanding Access to Healthcare and Increased Healthcare Investments to Propel Market
10.6.2 Macroeconomic Outlook for Middle East & Africa
10.7 GCC Countries
10.7.1 Advancements and Increased Government Investments in Healthcare Sector to Propel Market
10.7.2 Macroeconomic Outlook for GCC Countries
11 Competitive Landscape
11.1 Overview
11.2 Key Player Strategies/Right to Win
11.2.1 Overview of Strategies Deployed by Players in Fusion Biopsy Market
11.3 Revenue Share Analysis, 2021-2023
11.4 Market Share Analysis, 2023
11.5 Company Evaluation Matrix: Key Players, 2023
11.5.1 Stars
11.5.2 Emerging Leaders
11.5.3 Pervasive Players
11.5.4 Participants
11.5.5 Company Footprint: Key Players, 2023
11.5.5.1 Company Footprint
11.5.5.2 Region Footprint
11.5.5.3 Route Type Footprint
11.5.5.4 Product Footprint
11.5.5.5 Application Footprint
11.5.5.6 End-user Footprint
11.6 Company Evaluation Matrix: Startups/SMEs, 2023
11.6.1 Progressive Companies
11.6.2 Starting Blocks
11.6.3 Responsive Companies
11.6.4 Dynamic Companies
11.6.5 Competitive Benchmarking: Startups/SMEs, 2023
11.7 Company Valuation & Financial Metrics, 2024
11.8 Brand/Product Comparison
11.9 Competitive Scenario
11.9.1 Product Launches & Approvals
11.9.2 Deals
12 Company Profiles
12.1 Key Players
12.1.1 Koninklijke Philips N.V.
12.1.1.1 Business Overview
12.1.1.2 Products Offered
12.1.1.3 Analyst's View
12.1.1.3.1 Key Strengths
12.1.1.3.2 Strategic Choices
12.1.1.3.3 Weaknesses & Competitive Threats
12.1.2 GE Healthcare
12.1.2.1 Business Overview
12.1.2.2 Products Offered
12.1.2.3 Analyst's View
12.1.2.3.1 Right to Win
12.1.2.3.2 Strategic Choices
12.1.2.3.3 Weaknesses & Competitive Threats
12.1.3 Koelis
12.1.3.1 Business Overview
12.1.3.2 Products Offered
12.1.3.3 Recent Developments
12.1.3.3.1 Deals
12.1.3.4 Analyst's View
12.1.3.4.1 Right to Win
12.1.3.4.2 Strategic Choices
12.1.3.4.3 Weaknesses & Competitive Threats
12.1.4 Fujifilm Holdings Corporation
12.1.4.1 Business Overview
12.1.4.2 Products Offered
12.1.4.3 Recent Developments
12.1.4.3.1 Product Launches & Approvals
12.1.5 Canon Inc.
12.1.5.1 Business Overview
12.1.5.2 Products Offered
12.1.6 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
12.1.6.1 Business Overview
12.1.6.2 Products Offered
12.1.7 Esaote Spa
12.1.7.1 Business Overview
12.1.7.2 Products Offered
12.1.8 Eigen Health
12.1.8.1 Business Overview
12.1.8.2 Products Offered
12.2 Other Players
12.2.1 Focal Healthcare
12.2.2 Mtt GmbH
12.2.3 Medcom
12.2.4 Uc-Care Medical Systems
12.2.5 Biobot Surgical
13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options
List of Figures
Figure 1 Fusion Biopsy Market Segmentation & Regional Scope
Figure 2 Fusion Biopsy Market: Research Design
Figure 3 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
Figure 4 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 5 Fusion Biopsy Market: Revenue Share Analysis
Figure 6 Approach Based on Patient Population
Figure 7 Approach Based on Number of Hospitals
Figure 8 CAGR Projections: Supply-Side Analysis
Figure 9 Fusion Biopsy Market: Top-Down Approach
Figure 10 Data Triangulation Methodology
Figure 11 Fusion Biopsy Market, by Route Type, 2024 vs. 2029 (USD Million)
Figure 12 Fusion Biopsy Market, by Product, 2024 vs. 2029 (USD Million)
Figure 13 Fusion Biopsy Market, by Application, 2024 vs. 2029 (USD Million)
Figure 14 Fusion Biopsy Market, by End-user, 2024 vs. 2029 (USD Million)
Figure 15 Geographical Snapshot of Fusion Biopsy Market
Figure 16 Increasing Prevalence of Prostate Cancer to Drive Market Growth
Figure 17 Prostate Cancer Segment Accounted for Largest Share of North American Market in 2023
Figure 18 China to Register Highest Growth Rate During Forecast Period
Figure 19 Asia-Pacific to Witness Highest Growth During Forecast Period
Figure 20 Developing Markets to Register Higher Growth During Forecast Period
Figure 21 Fusion Biopsy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 22 Value Chain Analysis of Fusion Biopsy Market: Major Value Added During Manufacturing and Assembly Phases
Figure 23 Fusion Biopsy Market: Supply Chain Analysis
Figure 24 Fusion Biopsy Market: Ecosystem Analysis
Figure 25 Key Players in Fusion Biopsy Market Ecosystem
Figure 26 Fusion Biopsy Market: Porter's Five Forces Analysis
Figure 27 Influence of Stakeholders on Buying Process of Fusion Biopsy End-users
Figure 28 Key Buying Criteria for Fusion Biopsy End-users
Figure 29 Patent Analysis for Fusion Biopsy Market, January 2014-October 2024
Figure 30 Trends and Disruptions Impacting Customer Business in Fusion Biopsy Market
Figure 31 Fusion Biopsy Market: Investment & Funding Scenario
Figure 32 North America: Fusion Biopsy Market Snapshot
Figure 33 Asia-Pacific: Fusion Biopsy Market Snapshot
Figure 34 Revenue Share Analysis of Top Players in Fusion Biopsy Market, 2021-2023
Figure 35 Market Share Analysis of Key Players in Fusion Biopsy Market (2023)
Figure 36 Fusion Biopsy Market: Company Evaluation Matrix (Key Players), 2023
Figure 37 Fusion Biopsy Market: Company Evaluation Matrix (Startups/SMEs), 2023
Figure 38 EV/Ebitda of Key Vendors, 2024
Figure 39 Year-To-Date (Ytd) Price Total Return and Five-Year Stock Beta of Key Vendors
Figure 40 Fusion Biopsy Market: Brand/Product Comparative Analysis
Figure 41 Koninklijke Philips N.V.: Company Snapshot (2023)
Figure 42 GE Healthcare: Company Snapshot (2023)
Figure 43 Fujifilm Holdings Corporation: Company Snapshot (2024)
Figure 44 Canon Inc.: Company Snapshot (2023)
Figure 45 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.: Company Snapshot (2022)

Companies Mentioned

  • Koninklijke Philips N.V.
  • GE Healthcare
  • Koelis
  • Fujifilm Holdings Corporation
  • Canon Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Esaote Spa
  • Eigen Health
  • Focal Healthcare
  • Mtt GmbH
  • Medcom
  • Uc-Care Medical Systems
  • Biobot Surgical

Table Information

Report AttributeDetails
No. of Pages197
PublishedDecember 2024
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 0.65 Billion
Forecasted Market Value ( USD ) by 2029 $ 0.91 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030 - Product Image

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Fusion Biopsy System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Fusion Biopsy System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 93 Pages
  • Global
From
Cancer Biopsy Market Analysis & Forecast to 2024-2034: Market By Type; By Product; By Application; and By Region - Product Image

Cancer Biopsy Market Analysis & Forecast to 2024-2034: Market By Type; By Product; By Application; and By Region

  • Report
  • 200 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.